View from Brussels

Peter O'Donnell is a freelance journalist who specializes in European health affairs and is based in Brussels, Belgium.

Articles

With lessons from COVID now established, concrete ideas on improving drug development strategy for future health threats are beginning to take shape.

Speeding Up European Clinical Trials in Response to Emergencies 

EU’s sweeping push for major pharma reforms to impact the daily practice of clinical trials community.

European Legislative Proposals Presage New Rules for Clinical Trials

Dissecting the EMA’s new annual report on milestones reached in clinical research and public health.

Transformations Past and Future for the European Medicines Agency

Grading the government’s formal response to reform efforts hopeful of boosting UK’s sagging global standing in drug development.

Agenda Aims to Recharge UK-Based Clinical Trial Innovation

EMA operated-Priority Medicines scheme receives update which will expedite response to applicants.

Europe Enhances Regulatory Support for Tackling Unmet Medical Need

The hopes for increased transparency in clinical research beginning to take shape as sponsors get up to speed with new reporting obligations.

Filling the Gaps in European Clinical Trial Reporting

Europe trade and lobby group says implementation issues related to the legislation could impact 420 trials—and 42,200 patients—over the next three years.

EFPIA: Trials Hampered by New Rules on In Vitro Diagnostics

Latest project centers on partnership to align PM innovation with sustainable healthcare. 





Is Europe Inching Toward a Common Approach to Personalized Medicine?

Reformed EMA looks to tackle challenges in drug development, pediatric medicines, and unmet medical need.

Hints on Looming Changes to European Clinical Trial Rules

The Association of the British Pharmaceutical Industry greets the development with mix of relief and urgency.